pipette
ESEspañol

Small-molecule targeting of kinesin-13 KIF2C enhances double-strand break DNA repair and slows down aging

Joana Catarina Macedo, Marcos Antonio Barbosa Da Silva, Carlos Sousa-Soares, Joana Magalhães, M. Inês Ala, Rui Ribeiro, Monika Barroso‐Vilares, Mafalda Galhardo, Mafalda Sousa, Elsa D. Silva, Andrei Seluanov, Vera A. Gorbunova, Paula Sampaio, Francisco Vasques‐Nóvoa, Diana Santos Nascimento, Elsa Logarinho

Peer-reviewed journalReal-world use

In the authors' words

DNA damage is a central driver of the aging process. We previously found that the kinesin-13 KIF2C, shown to play a role in DNA repair, is repressed in aged cells. Here, we investigate whether increased KIF2C activity can counteract DNA damage and alleviate aging-related phenotypes. We demonstrate that a small-molecule agonist of KIF2C enhances DNA repair in two distinct genetic disorders characterized by pervasive DNA damage and accelerated aging: the Hutchinson-Gilford progeria syndrome (HGPS) and the Down syndrome (DS). Mechanistically, the KIF2C agonist improves double-strand break (DSB) DNA repair in aged and patient-derived cells by restoring the assembly of nuclear envelope invaginations driven by cytoplasmic microtubules. Enhanced DSB DNA repair in HGPS and DS cells translates into amended nuclear structure and transcriptional signatures. Moreover, subcutaneous administration of the KIF2C agonist in progeria mice mitigates aging phenotypes and extends both health and lifespan. Our study discloses a geroprotective pharmacological approach that acts by hindering DSB DNA damage, and thus we demonstrate that enhanced genome stability can delay aging. DNA damage is associated with aging and premature aging disorders. Here, the authors show that small molecule activation of the kinesin-13 KIF2C improves double-strand break DNA repair in aged cells and extends lifespan in progeria mice.

Main resultThe abstract does not state a limitation.

In plain words AI summary

DNA damage drives aging, and a protein called KIF2C that helps repair DNA is reduced in aged cells. The researchers tested whether boosting KIF2C activity could counteract DNA damage and aging. A small molecule that activates KIF2C improved DNA repair in cells from patients with two premature aging disorders. The molecule fixed double-strand DNA breaks by restoring structures in the cell nucleus that are built by microtubules. Injecting the KIF2C activator into progeria mice reduced aging signs and extended their healthy lifespan.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Tuesday, November 3. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-79165-6